MABC is a significant pathogen for immunocompromised patients, and identifying its subspecies accurately is crucial for effective antibiotic treatment.
Researchers developed specific PCR assays for MABC subspecies using comparative genomics, which highlighted distinct genetic clusters among the subspecies.
The study confirmed that these PCR assays are highly sensitive and specific, allowing for reliable identification of MABC subspecies, thus aiding in better diagnosis and treatment decisions.